Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification  by Nicolaides, Andrew N. et al.
From the Society for Vascular Surgery
Asymptomatic internal carotid artery stenosis and
cerebrovascular risk stratification
Andrew N. Nicolaides, MS, FRCS, PhD (Hon),a Stavros K. Kakkos, MD, MSc, PhD, DIC,a
Efthyvoulos Kyriacou, BSc, PhD,b Maura Griffin, MSc, DIC, PhD,a Michael Sabetai, MD, FRCS, PhD,a
Dafydd J. Thomas, MD, PhD,c Thomas Tegos, MD, PhD,a George Geroulakos, MD, PhD,a,d
Nicos Labropoulos, PhD, DIC, RVT,e Caroline J. Doré, BSc,f Tim P. Morris, MSc,f
Ross Naylor, MD, FRCS,g and Anne L. Abbott, MB, BS, FRACP, PhD,h,i for the Asymptomatic Carotid
Stenosis and Risk of Stroke (ACSRS) Study Group, London and Leicester, United Kingdom; Limassol,
Cyprus; Stony Brook, NY; and Melbourne, Australia
Background:The purpose of this study was to determine the cerebrovascular risk stratification potential of baseline degree
of stenosis, clinical features, and ultrasonic plaque characteristics in patients with asymptomatic internal carotid artery
(ICA) stenosis.
Methods: This was a prospective, multicenter, cohort study of patients undergoing medical intervention for vascular
disease. Hazard ratios for ICA stenosis, clinical features, and plaque texture features associated with ipsilateral
cerebrovascular or retinal ischemic (CORI) events were calculated using proportional hazards models.
Results: A total of 1121 patients with 50% to 99% asymptomatic ICA stenosis in relation to the bulb (European Carotid
Surgery Trial [ECST] method) were followed-up for 6 to 96 months (mean, 48). A total of 130 ipsilateral CORI events
occurred. Severity of stenosis, age, systolic blood pressure, increased serum creatinine, smoking history of more than 10
pack-years, history of contralateral transient ischemic attacks (TIAs) or stroke, low grayscale median (GSM), increased
plaque area, plaque types 1, 2, and 3, and the presence of discrete white areas (DWAs) without acoustic shadowing were
associated with increased risk. Receiver operating characteristic (ROC) curves were constructed for predicted risk versus
observed CORI events as a measure of model validity. The areas under the ROC curves for a model of stenosis alone, a
model of stenosis combined with clinical features and amodel of stenosis combined with clinical, and plaque features were
0.59 (95% confidence interval [CI] 0.54-0.64), 0.66 (0.62-0.72), and 0.82 (0.78-0.86), respectively. In the last model,
stenosis, history of contralateral TIAs or stroke, GSM, plaque area, and DWAs were independent predictors of ipsilateral
CORI events. Combinations of these could stratify patients into different levels of risk for ipsilateral CORI and stroke,
with predicted risk close to observed risk. Of the 923 patients with>70% stenosis, the predicted cumulative 5-year stroke
rate was <5% in 495, 5% to 9.9% in 202, 10% to 19.9% in 142, and >20% in 84 patients.
Conclusion: Cerebrovascular risk stratification is possible using a combination of clinical and ultrasonic plaque features.
These findings need to be validated in additional prospective studies of patients receiving optimal medical intervention
alone. (J Vasc Surg 2010;52:1486-96.)From the Department of Vascular Surgery, Imperial College, London, UK;a
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1486Studies performed in the 1980s and 1990s1-10 have
indicated that the risk of stroke in asymptomatic patients is
0.1% to 1.6% per year for internal carotid artery (ICA)
stenosis 75% to 80% (North American Symptomatic Ca-
rotid Endarterectomy Trial [NASCET] method; ie, in re-
lation to the diameter of the normal distal internal carotid
artery) and 2.0% to 3.3% per year with greater degrees of
stenosis.
Two randomized controlled trials, the Asymptomatic
Carotid Atherosclerosis Study (ACAS) in 199511 and
Asymptomatic Carotid Surgery Trial (ACST) in 2004,12
reported that in patients with asymptomatic ICA stenosis
60% to 70% (NASCET) carotid endarterectomy reduced
the risk of stroke from2% to1%per year. In these trials, carotid
endarterectomy was associated with a 2% to 3% perioperative
rate of stroke or death.However, medical intervention, which
was left to the discretion of the local teams, was suboptimal in
relation to current practice. For example, in the ACST, statins
and antiplatelet agents were administered to only 25% and
80% of patients, respectively.12
Currently, vascular disease medical intervention in-
cludes ongoing risk factor diagnosis, patient education,
support of healthy lifestyle practices, and medications. Best
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cerebral stroke among patients with asymptomatic moder-
ate-severe ICA stenosis receiving medical intervention
alone has fallen to approximately 1%13,14 making routine
carotid endarterectomy unjustified. However, if patient
subgroups with sufficiently higher average risk, despite
current optimal medical intervention, could be reliably
identified, then carotid surgery may still be justified.
Studies of duplex-determined carotid plaque images
have found that hypoechoic (echolucent, mainly black) and
heterogenous plaques (plaques with mixed black and white
areas) are more often associated with cerebrovascular symp-
toms than those which are hyperechoic (uniformly white or
calcified).1,2,15-20 Two recent prospective studies have
demonstrated that hypoechoic plaques with low grayscale
median (GSM) were associated with a threefold to fourfold
increase in stroke.21,22 Other duplex-determined plaque
features reported to be associated with symptomatic
plaques are plaque area,23 and plaque heterogeneity as
indicated by the presence of noncalcified (absence of acous-
tic shadow) discrete white areas (DWAs) within black ar-
eas.24 However, the potential of combinations of such
methods for stratifying the risk of ipsilateral stroke/tran-
sient ischemic attack (TIA) in patients with asymptomatic
carotid stenosis has not been investigated. Limitations of
previous ultrasound scan studies of carotid plaque mor-
phology include retrospective design, small samples, lack of
subcategorization of stenosis severity, and lack of differen-
tiation between ipsilateral and any territory ischemic symp-
toms.
The Asymptomatic Carotid Stenosis and Risk of Stroke
(ACSRS) study, was a multicenter cohort study of patients
with asymptomatic ICA stenosis undergoing vascular dis-
ease medical intervention alone. The objective was to assess
the cerebrovascular risk stratification potential of combina-
tions of patients’ clinical and biochemical characteristics,
and the ultrasound scan-determined degree of stenosis and
plaque morphology.
METHODS
Patient recruitment
Inclusion criteria. Newly referred (3 months) pa-
tients with 50% to 99% ICA stenosis in relation to the
carotid bulb diameter (European Carotid Surgery Trial
[ECST] method) without previous ipsilateral cerebral
or retinal ischemic (CORI) symptoms and without neuro-
logical abnormality were recruited to the study after they
provided written informed consent. Patients who had con-
tralateral cerebral hemispheric/retinal or vertebrobasilar
symptoms or signs of stroke/TIA were included if asymp-
tomatic for at least 6 months prior to recruitment. For
patients with bilateral asymptomatic carotid atherosclero-
sis, the side with the more severe stenosis was considered
ipsilateral (the study artery).
Exclusion criteria. Patients who could not attend for
6 monthly neurological assessments, and those with a lim-
ited life expectancy because of conditions such as severecardiac failure or disseminated malignancy, were excluded
from this study.
Recruitment sources. The participating centers, their
eligibility criteria, and quality control procedures have been
published previously25-28 and are summarized in the online
data supplement.
Study approval. Approval was obtained from the
Multicenter Research Ethics Committee (North Thames,
London, UK) and local ethics committees.
Clinical and biochemical characteristics. At baseline,
all patients had a history taken and a physical examination by
the local neurologist, electrocardiographic (ECG) examina-
tion, and collection of fasting blood for determination of the
following:
● Age, gender, body mass index (BMI), systolic and
diastolic blood pressure, smoking history, and accrued
pack-years.
● Medication usage including antiplatelet, antihyperten-
sive, and lipid lowering agents.
● Presence of hypertension (antihypertensive medica-
tion or BP 140 mm Hg systolic or 90 mm Hg
diastolic), coronary artery disease (documented myo-
cardial infarction [MI]/angina, coronary artery bypass
or stenting), diabetes (antihyperglycemic therapy or
fasting blood glucose 120 mg/dL), and previous
contralateral stroke/TIA or vertebrobasilar symp-
toms.
● ECG evidence of atrial fibrillation, previous MI, myo-
cardial ischemia, and left ventricular hypertrophy
(LVH) on baseline ECG according to previously pub-
lished criteria.25 ECGs were reported at the coordinat-
ing center by two cardiologists.
● Fibrinogen, fasting lipids (total cholesterol, HDL-
cholesterol, LDL-cholesterol, triglycerides), serum
creatinine, and hematocrit.
Duplex examination. Bilateral carotid duplex scan-
ning was performed on admission to the study. Ultra-
sonographers from all centers were trained at the coordi-
nating center in grading internal carotid stenosis and
plaque image capture.25 The entire duplex examination,
recorded on S-VHS videotape, was sent to the coordinating
center for quality control.
Grading of internal carotid stenosis. A combination
of velocity criteria was used to express the degree of stenosis
in terms of both the ECST method and the NASCET
method25,29 (see online data supplement). ECST stenosis
was used in analysis because of its linear relationship to risk
of ipsilateral CORI events, unlike NASCET stenosis which
has an S-shaped relationship.28 Contralateral ICA occlu-
sion was noted. Bilateral vertebral artery flow was reported
as cephalad, reversed, or not visualized.
Image normalization, segmentation, and analysis.
Baseline images from video recordings were digitized off-
line on a PC using a video grabber card (Videologic, TV
Snap version 1.0.3 c 1994) at a resolution of 640  480
pixels at the coordinating center by two members of the
team who were experienced in carotid scanning. Image
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“blood” (grayscale  0) and adventitia (grayscale  190),
and pixel density standardization to 20 pixels per mm were
performed followed by image analysis. The “Plaque Tex-
ture Analysis software” version 3.2 (Iconsoft International
Ltd, Greenford, London, UK)30 was used. Some plaque
texture features were automatically calculated using the
“Feature Extraction” module of the software: GSM,30
modified Geroulakos plaque classification18,27 and
plaque area. Presence of DWAs without acoustic shad-
owing and ulceration were identified visually (see online
Table I. Baseline clinical, biochemical, and ultrasonic
features in 1121 patients
Continuous variables (normal distribution; mean  SD)
Age, year 70.0  7.7
BMI (kg/m2)a 25.4  3.7
SBP (mm Hg)a 152.3  22.2
DBP (mm Hg)a 82.2  10.0
Creatinine (mol/L)a 100.5  34.1
Fibrinogen (g/L)a 3.56  1.00
Hematocrit (%)a 41.1  4.9
Total cholesterol (mmol/dL)a 6.01  1.19
LDL cholesterol (mmol/dL)a 3.90  1.20
HDL cholesterol (mmol/dL)a 1.30  0.49
Ipsilateral stenosis (%) 78.0  12.8
Contralateral stenosis (%) 45.5  30.0
Continuous variables (skewed distribution; median,
interquartile range)
Pack-years 10 (0, 36)
Triglycerides (mmol/dL)a 1.58 (1.17, 2.19)
Grayscale median (GSM) 32.2 (17.1, 50.6)
Plaque area (mm2) 41.9 (27.1, 60.2)
Categorical variables
Gender: female 438 (39%)
Smoking at entry 212 (19%)
Coronary artery disease 379 (34%)
Atrial fibrillation 29 (2.6%)
Hypertension 709 (63%)
Diabetes 231 (21%)
History of contralateral TIAs or stroke 173 (15%)
History of vertebrobasilar symptoms 136 (12%)
Old MI on ECG 201 (18%)
Ischemia on ECG 238 (21%)
LVH on ECG 116 (10%)
Antihypertensive therapy 674 (60%)
Antiplatelet therapy 940 (84%)
Lipid lowering therapy 278 (25%)
Ipsilateral vertebral flow not detected or
reversed
90 (8%)
Contralateral internal carotid occlusion 93 (8%)
Ipsilateral ultrasonic ulcer 101 (10%)
Plaque types 4 and 5 186 (17%)
Plaque type 3 509 (45%)
Plaque type 2 341 (30%)
Plaque type 1 85 (8%)
Presence of discrete white areas 718 (64%)
BMI, Body mass index; DBP, diastolic blood pressure; ECG, electrocardio-
gram; LVH, left ventricular hypertrophy; MI, myocardial infarction; SBP,
systolic blood pressure; TIAs, transient ischemic attacks.
aPercentages of missing values were: BMI 4%, SBP 10%, DBP 10%, creati-
nine 11%, fibrinogen 23%, hematocrit 12%, total cholesterol 11%, LDL 22%,
HDL 22%, triglycerides 12%.data supplement).Outcome measures. Primary outcome measures were
(1) ipsilateral CORI events (ie, cerebral or retinal ischemic
events that included stroke) and (2) ipsilateral cerebral
ischemic stroke (fatal or nonfatal). Stroke and TIA were
defined as cerebral deficits most likely of vascular origin
lasting 24 hours or 24 hours, respectively. For each
stroke, details recorded by the local neurologist, a 6-month
modified Rankin score,31 and computed tomography (CT)
or magnetic resonance imaging (MRI) brain scan results
were requested. Two coordinating center members includ-
ing a neurologist, made the final classification of ipsilateral
strokes. Local team members diagnosed amaurosis fugax
TIAs and vertebrobasilar strokes.
Secondary outcomemeasures were all other strokes and
TIAs, contralateral retinal vascular events, and all other
deaths. Cause of death was determined by local teammem-
bers, using death certificates, hospital records, and family
doctor information.
Study exit points. Follow-up ceased with the first
occurrence of any of the following: the first primary out-
come measure, carotid endarterectomy/angioplasty or
stenting for the still asymptomatic study artery, death from
causes other than ipsilateral stroke, or loss to follow-up.
Stroke,TIA,ordeathassociatedwithcarotidendarterectomy/
angioplasty or stenting for the still asymptomatic study
artery were not included in event rate calculations.
Statistical analysis. Stata (versions 10.1 and 11; Stata-
Corp, College Station, Tex) was used for statistical analysis
and production of graphs.
Initially, Kaplan-Meier curves were used for the whole
cohort of 1121 patients to determine overall ipsilateral
CORI event and stroke-free survival over time. Stratified
Kaplan-Meier curves were also constructed for percentage of
Table II. Ipsilateral cerebral or retinal ischemic (CORI)
events (AF, TIAs, and stroke) and ipsilateral ischemic
cerebral stroke for all patients and subgroups according to
ECST stenosisa as used in this paper and NASCET
stenosisb for comparison with previous publications that
have used these methods.
ECST
stenosis (%)
NASCET
stenosis (%) No. CORI events Strokes
All patients 1121 130 (11.6%) 59 (5.3%)
50-69a 50 198 16 (8.1%) 5 (2.5%)
70-89a 50-82 598 65 (10.9%) 29 (4.8%)
90-99a 83-99 325 49 (15.1%) 25 (7.7%)
P  .01 P  .008
80 70b 514 50 (9.7%) 21 (4.1%)
80-99 70-99b 607 80 (13.2%) 38 (6.3%)
P  .07 P  .10
AF, Atrial fibrillation; CORI, cerebrovascular or retinal ischemic; ECST,
European Carotid Surgery Trial; NASCET, North American Symptomatic
Carotid Endarterectomy Trial; TIAs, transient ischemic attacks.
Follow-up 6 months to 8 years (mean, 48 months). P values were calculated
using chi-square test for trend.stenosis, history of contralateral TIAs or stroke, DWAs,
ne 11%
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for stratified Kaplan-Meier plots. For example, stenosis was
categorized asmild (70%ECST/50%NASCET),moder-
ate (70% to 89% ECST/50% to 82% NASCET) or severe
(90% to 99% ECST/83% to 99% NASCET).
Subsequently, hazard ratios for clinical, biochemical,
and ultrasonic features for ipsilateral CORI events and
stroke were determined using an unadjusted Coxmodel for
each variable. Continuous risk factors were transformed to
an unskewed distribution where possible.
Risk factors which were significant at P  .05 in unad-
justed models for CORI events or stroke were considered
in multivariable proportional hazards models. Flexible
parametric models of Royston & Parmar32 were used be-
cause the baseline hazard function at 5 years was of interest,
Table III. Unadjusted hazard ratios (HRs) of risk factors
(Skewed continuous predictors were transformed to be app
Risk factor CORI HR
Age (10 year increase) 1.10
BMI (5 unit increase)a 0.86
Systolic blood pressure (10 unit increase)a 1.11
Diastolic blood pressure (10 unit increase)a 1.21
Creatinine (20% increase)a 1.10
ln (GSM40) 0.08
Fibrinogena 1.03
Hematocrit (10 unit increase)a 1.18
Total cholesterola 1.08
LDL cholesterola 1.03
HDL cholesterola 1.12
Triglyceride (doubling)a 1.18
Ipsilateral stenosis (10% increase) 1.02
Contralateral stenosis (10% increase) 1.03
Plaque area (mm2)1/3 2.51
Plaque types 4 & 5 1
3. 6.31
2. 19.66
1. 18.28
Male 0.92
Smoking 1.10
10 smoking pack-years 1.65
Coronary artery disease 1.19
Atrial fibrillation 1.36
Hypertension 0.98
Diabetes 0.77
History of vertebrobasilar symptoms 1.48
History of contralateral TIAs or stroke 2.35
Old MI on ECG 1.31
Ischemia on ECG 1.41
LVH on ECG 1.03
Antihypertensive therapy 0.94
Antiplatelet therapy 0.98
Lipid lowering therapy 0.87
Ipsilateral vertebral flow 1.74
Contralateral internal carotid occlusion 1.27
Ipsilateral ultrasonic ulcer 0.52
Presence of DWAs (1) 2.32
BMI, Body mass index; CI, confidence interval; CORI, cerebrovascular o
grayscale median; LVH, left ventricular hypertrophy; MI, myocardial infarc
HR with P  .05 are in bold.
aPercentages of missing values were: BMI 4%, SBP 10%, DBP 10%, creatini
22%, triglycerides 12%.which is erratic in Cox models. Hazard ratios from thesemodels were compared to equivalent Cox models. Model
(i) included stenosis and the significant clinical factors to
predict time to CORI event; model (ii) included stenosis,
the significant clinical factors and plaque features as covari-
ates; model (iii) was formulated identically to (ii) except the
dependent variable was time to stroke. Variable selection
was not used inmodel (iii) because of the smaller number of
events. Important prognostic variables were selected using
backwards elimination, with P  .05 as the condition for a
variable to be excluded. To relax the assumption that the
effect of covariates on the dependent variable must be
linear, multivariable, fractional polynomials were used.33
On the basis of model (iii), ipsilateral cerebral ischemic
stroke-free survival curves were produced for different com-
binations of risk factor subgroups from which 5-year stroke
silateral CORI events and ipsilateral cerebral stroke.
mately symmetrically distributed.)
95% CI Stroke HR 95% CI
(0.88-1.38) 1.42 (1.00-2.02)
(0.65-1.14) 0.85 (0.57-1.28)
(1.07-1.22) 1.07 (0.94-1.22)
(0.99-1.47) 1.14 (0.86-1.50)
(0.96-1.25) 1.28 (1.09-1.50)
(0.04-0.15) 0.06 (0.02-0.15)
(0.85-1.26) 1.17 (0.84-1.48)
(0.83-1.66) 1.13 (0.07-1.85)
(0.92-1.26) 1.02 (0.80-1.28)
(0.86-1.23) 0.97 (0.74-1.27)
(0.75-1.69) 1.34 (0.80-2.24)
(0.80-1.74) 1.73 (0.99-3.05)
(1.01-1.04) 1.04 (1.01-1.06)
(0.98-1.10) 1.05 (0.96-1.14)
(2.01-3.12) 2.45 (1.76-3.40)
— 1 —
(1.52-26.19) 4.41 (0.58-33.74)
(4.83-80.06) 18.79 (2.58-137.03)
(4.20-79.52) 20.74 (2.63-163.70)
(0.65-1.30) 1.10 (0.65-1.86)
(0.72-1.70) 1.51 (0.84-2.71)
(1.16-2.34) 1.52 (0.90-2.56)
(0.84-1.70) 1.32 (0.78-2.21)
(0.50-3.68) 1.55 (0.38-6.36)
(0.68-1.40) 1.00 (0.59-1.70)
(0.48-1.25) 0.88 (0.45-1.74)
(0.92-2.38) 1.48 (0.73-3.00)
(1.60-3.43) 3.03 (1.77-5.20)
(0.87-1.97) 1.62 (0.91-2.87)
(0.95-2.08) 1.36 (0.76-2.45)
(0.59-1.80) 1.15 (0.52-2.53)
(0.66-1.34) 0.94 (0.56-1.59)
(0.60-1.59) 1.05 (0.50-2.20)
(0.58-1.29) 0.81 (0.45-1.48)
(0.88-3.42) 3.72 (0.91-15.24)
(0.71-2.25) 1.05 (0.42-2.62)
(0.24-1.11) 0.48 (0.15-1.55)
(1.49-3.6) 1.68 (0.92-3.06)
al ischemic; DWAs, discrete white areas; ECG, electrocardiogram; GSM,
, fibrinogen 23%, hematocrit 12%, total cholesterol 11%, LDL 22%, HDLfor ip
roxi
r retin
tion.rates were calculated.
s, disc
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using the Schoenfeld residuals. Harrell’s C34 and a pseudo
R2 were calculated35 for models (i-iii). Harrell’s C is a
measure of discrimination which calculates the proportion
of time that survival times for pairs of patients can be
correctly ordered, on the basis of covariates in the model.
Pseudo R2 is analogous to the standard R2 (proportion of
explained variation) adapted to models for censored sur-
vival data.
The covariates included in a model were used to calcu-
late the linear predictor score, x (the sum of the product
of mean-centered covariate values and corresponding pa-
rameter estimates) for each patient. Receiver operating
characteristic (ROC) curves were constructed for x
against observed 5-year CORI event rates (in the same set
of patients). These were compared for the unadjusted
ECST stenosis model and models (i) and (ii). This was also
done separately for model (iii), since comparison of differ-
ent x for different dependent variables is inappropriate.
For model (iii), internal calibration was assessed by com-
paring predicted risk of stroke at 5 years to the observed
proportion experiencing stroke by 5 years.
Role of the funding source. Study sponsors had no
role in the design, conduct, or reporting of this research.
RESULTS
A total of 1121 patients aged 39 to 89 years (mean age
70.0; SD 7.7; 61% men) were recruited during 1998 to
2002 with a follow-up of 6 to 96 months (mean, 48
months). There was 66% of patients recruited frommedical
Table IV. Flexible parametric proportional hazards mode
CORI events as the dependent variable. Selected using bac
overlapping 1 in Table III
Variable
(i) Clinical factors only. Ipsilateral CORI events as the dependent
C  .66; Pseudo R2  .17
Stenosis (% ECST)
Pack-years (10, 10)
History of contralateral TIAs and/or stroke (Yes vs no)
(ii) Clinical factors with plaque features. Ipsilateral CORI events a
Harrell’s C  .79; Pseudo R2  .55
Stenosis (% ECST)
Log (GSM  40)
Plaque area1/3 (mm2)
DWAs (Present vs absent)
History of contralateral TIAs and/or stroke (Yes vs no)
(iii) Clinical factors with plaque features. Ipsilateral hemispheric st
performed here because of too few events. Variables were ide
Harrell’s C  .80; Pseudo R2  .61
Stenosis (% ECST)
Log (GSM  40)
Plaque area1/3 (mm2)
DWAs (Present vs absent)
History of contralateral TIAs and/or stroke (Yes vs no)
CI, Confidence interval; CORI, cerebrovascular or retinal ischemic; DWA
median; HR, hazard ratio; TIAs, transient ischemic attacks.services (vascular internists, 28%; neurologists, 16%; cardi-ologists, 10%; hypertension clinics, 5%;metabolic units, 3%;
and screening programs, 4%). Thirty-four percent of pa-
tients were recruited from surgical services (vascular, 32%;
cardiac surgery, 2%). Baseline distribution of patient clinical
and biochemical characteristics, degree of stenosis, and
other plaque features are presented in Table I.
Ipsilateral cerebrovascular events. A total of 130
first ipsilateral CORI events occurred (59 strokes of which
12 were fatal, 49 TIAs, and 22 amaurosis fugax). For
ischemic stroke, the modified Rankin scale at 6 months was
zero in 4 cases, 1 in 9 cases, 2 in 6 cases, 3 in 8 cases, 4 in 18
cases, 5 in 2 cases, and 6 in 12 cases. There were two
additional first ipsilateral fatal hemorrhagic strokes.
Severe and fatal ipsilateral strokes (n  14; Rankin
scores 5 and 6) occurred exclusively in plaque types 1 and 2
(10 in type 2 and 4 in type 1); also exclusively in plaques
with GSM 30 (4 in plaques with GSM 15-30, and 10 in
plaques with GSM15). Seven of these strokes occurred in
the 231 patients with diabetes with the other 7 in the
remaining 890 patients (P  .006; odds ratio [OR], 3.94;
95% confidence interval [CI], 1.37-11.35). Five of these
strokes occurred in the 173 patients with a history of
contralateral TIA or stroke (P  .035; OR, 3.10; 95% CI,
1.03-9.38).
Other outcome measures. There were 49 first con-
tralateral CORI events: 18 ischemic strokes of which 7 were
fatal, 22 TIAs, and 9 amaurosis fugax. There were two verte-
brobasilar strokes. Of the 18 contralateral strokes, 4 occurred
in the 125 patients with plaques producing 90% to 99% stenosis,
1 in the 170 producing 70% to 89% stenosis, and the remain-
luding significant variables from Table III with ipsilateral
d elimination on all variables with 95% CI not
 HR 95% CI P value
ble. Five-year baseline hazard estimated as .886; Harrell’s
028 1.03 1.01-1.04 .001
429 1.53 1.07-2.18 .018
858 2.36 1.61-3.46 .001
dependent variable. Five-year baseline hazard estimated as .949;
01696 1.02 1.00-1.03 .027
4519 0.09 0.04-0.17 .001
6539 1.92 1.50-2.46 .001
7417 2.10 1.32-3.35 .002
6901 1.99 1.32-2.92 .001
as the dependent variable. Note no variable selection was
to those used in (ii). Five-year baseline hazard estimated as .972;
026 1.03 1.00-1.05 .024
672 0.07 0.02-0.20 .0001
629 1.88 1.28-2.75 .0001
429 1.54 0.81-2.92 .18
973 2.65 1.54-4.54 .0001
rete white areas; ECST, European Carotid Surgery Trial; GSM, grayscalels inc
kwar
varia
0.
0.
0.
s the
0.
	2.
0.
0.
0.
roke
ntical
0.
	2.
0.
0.
0.ing 13 in the 826 producing less than 70% stenosis. Plaque
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The only factor associated with contralateral stroke was the
presence of atrial fibrillation (OR, 8.28; 95% CI, 2.26-30).
There was a total of 214 deaths (195 non-stroke
Fig 1. Kaplan-Meier plots showing ipsilateral cerebrova
by: (A) European Carotid Surgery Trial (ECST ) steno
(GSM): log-rank test: P for trend  .0001; (C) plaque
white areas (DWA): log-rank test: P  .0001; (E) histor
log-rank test: P  .0001.deaths) of which 157 (73%) were due to vascular causes:MI, 110; fatal stroke, 19 (12 ipsilateral and 7 contralateral
already mentioned above); heart failure, 17; pulmonary
embolism, 3; lower limb ischemia/gangrene, 3; ruptured
abdominal aortic aneurysm, 3; renal failure, 1; and mesen-
or retinal ischemic (CORI) event-free survival stratified
g-rank test: P for trend  .002; (B) grayscale median
mm2): log-rank test: P for trend  .0001; (D) discrete
ontralateral transient ischemic attacks (TIAs) or stroke:scular
sis: lo
area (
y of cteric artery thrombosis, 1. There were 56 nonvascular
0.74-0.86).
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gastrointestinal hemorrhage, 2; dementia, 2; road traffic
accident, 2; and general surgical procedure, 1. Cause of
death was unknown in 1 patient.
Ipsilateral carotid endarterectomy was performed in
129 patients for a still asymptomatic study artery (stenosis
median: 85% ECST; interquartile range: 75-90) because
the clinician in charge or the patient requested it. This
occurred soon after publication of the ACST results. Of
these 129 patients, 11 (5.6%) were in the group of 198 with
less than 70% stenosis, 77 (12.9%) in the group of 598 with
70% to 89% stenosis, and 40 (12.3%) in the group of 325
with 90% to 99% stenosis. Twenty-one patients were lost to
follow-up. In these, contact was lost with 15 patients, 5
declined to re-attend (too old to travel), and 1 emigrated.
Thus, 150 patients (13.4%) have been “lost” from the
study. They have been included in the analysis up to the last
follow-up visit. The remaining 971 patients (86.6%) have
been followed up to a primary event, death, or termination
of the study in December 2006.
Ipsilateral event rates in relation to stenosis sev-
erity. The ipsilateral CORI events and strokes in relation
to subgroups of stenosis are shown in Table II. They
demonstrate that ipsilateral risk increases with increasing
stenosis across mild-severe categories.
Baseline features associated with increased ipsilat-
eral cerebrovascular risk. Hazard ratios for each individ-
ual baseline clinical, biochemical, and ultrasonic feature
associated with patients with ipsilateral CORI events and
strokes are shown in Table III. Ipsilateral stenosis, systolic
blood pressure, smoking history of more than 10 pack-
years, GSM, plaque area, plaque type, history of contralat-
eral TIAs or stroke, and presence of DWAs were significant
risk factors for CORI events. The hazard ratios for stroke
showed a similar pattern, although these were not always
statistically significant due to the lower number of events.
Table IV shows the results of three multivariable pro-
portional hazard models, (i-iii). Measures of model perfor-
mance Harrell’sC and pseudo R2 were greatly increased by
including plaque features. Powers of continuous covariates
remained untransformed by multivariable fractional poly-
nomials. Parameter estimates in Table IV were very similar
to those obtained using Cox models in each case.
The cumulative ipsilateral CORI event-free survival
Kaplan-Meier curves for each of the significant risk factors
in model (ii) are shown in Fig 1, A-E.
On the basis of the variables shown in Table IV, the
linear predictor scores x of models (i) and (ii) were
calculated for each patient. ROC curves constructed with
(a) stenosis (ECST) as a continuous variable, (b) the pre-
dictor score from model (i), and (c) the predictor score
from model (ii) are shown in Fig 2. The predictor score
from model (ii) that combined stenosis with clinical and
plaque texture features was associated with the largest area
under the ROC curve: 0.82 (95% CI, 0.77-0.85; Fig 2,A).
The area under the ROC curve from model (iii) which had
stroke as the dependent variable was 0.80 (95% CI, 0.74-Fig 2. Receiver operating characteristic (ROC) curves (A) for
cerebrovascular or retinal ischemic (CORI) events using (a) steno-
sis as continuous variable, (b) the linear predictor score from the
proportional hazards model (model i) that included stenosis and
significant clinical features only (pack-years, history of contralateral
transient ischemic attacks [TIAs] or stroke), and (c) the propor-
tional hazards model (model ii) that included stenosis, significant
clinical and plaque characteristics (grayscale median [GSM],
plaque area, discrete white areas [DWAs], and history of contralat-
eral TIAs or stroke) for predicting ipsilateral CORI events. Corre-
sponding areas under curve are (a) 0.59 (95% confidence interval
[CI], 0.54-0.64), (b) 0.66 (95% CI, 0.62-0.72), and (c) 0.82
(95% CI, 0.78-0.86). P .003 for all pairwise comparisons. ROC
curve for stroke (B) using the linear predictor score of the propor-
tional hazards model (model iii). Area under curve is 0.80 (95%CI,0.87; Fig 2, B).
served
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rates for ipsilateral cerebral stroke were estimated for differ-
ent combinations of risk factor subgroups (Table V). (To
calculate individual patient risk, see appendix in the online
data supplement). Fig 3 shows calibration for model (iii).
At low predicted probabilities, the model seems to slightly
over-predict. At higher predicted probabilities, the model
predicts very nicely, with estimates close to the line of
agreement and CIs overlapping. The predicted 5-year
percentage stroke rate (observed; 95% CI) was5% (very
low risk) in 654 (1%; 0.2-2), 5% to 9.9% (low risk) in 225
(8%; 5-13), 10% to 19.9% (moderate risk) in 156 (12%;
7-18), and20% (high risk) in 86 patients (29%; 14-33).
Of the 923 patients with 70% stenosis, 495 were
included in the very low, 202 in the low, 142 in the
Table V. Estimated percent risk of ipsilateral ischemic cerebral
Stenosis
History of contralateral
TIAs or stroke DW
Present
90% to 99% ECST
(83% to 99% NASCET)
Absent
Present
70% to 89% ECST
(50% to 82% NASCET)
Absent
DWAs, Discrete white areas; ECST, European Carotid Surgery Trial; GSM,
tomy Trial; TIAs, transient ischemic attacks.
—Denotes a covariate combination which did not occur in observed data.
aDenotes a covariate combination which occurred less than five times in obmoderate, and 84 in the high-risk group.DISCUSSION
The ACSRS study is the largest prospective study of
patients with asymptomatic carotid artery stenosis under-
going medical intervention alone. The results demonstrate
that a number of baseline clinical characteristics and ultra-
sonic plaque features are independent predictors of subse-
quent ipsilateral CORI events. Clinical features added to
stenosis improve prediction, and the further addition of
plaque features improves prediction even more. The results
also emphasize the high mortality mainly from MI in pa-
tients with asymptomatic carotid stenosis.
Smoking is an established risk factor for plaque progres-
sion, plaque rupture, and ischemic stroke.36,37 The in-
creased risk for ipsilateral stroke in patients with a history of
e within 5 years (for patients with70% ECST stenosis)
sent
Plaque area
(mm2) GSM
30 15-30 15
80 20.3a 52.8a —
40-80 13.8 35.8 70.0a
40 7.8a 20.1a —
80 13.3a 34.5a —
40-80 9.0a — 45.7a
40 5.1a 13.1a 25.7a
80 7.7a 20.0 39.1a
40-80 5.2 13.5 26.5
40 2.9 7.6 14.9a
80 5.0a 13.0a 25.5a
40-80 3.4a a 17.3
40 1.9 5.0 9.7a
80 13.8a 35.0a 70.4a
40-80 9.4 24.4a 47.7
40 5.3 13.7a 26.8
80 9.0a 23.5a —
40-80 6.1a 15.9a 31.1a
40 3.4 8.9a 17.4a
80 5.2 13.6 26.6
40-80 3.5 9.2 18.0
40 2.0 5.2 10.1
80 3.4a — 17.4
40-80 2.3 6.0 11.8
40 1.3 3.4 6.6
ale median; NASCET, North American Symptomatic Carotid Endarterec-
data.strok
As pre
Yes
No
Yes
No
Yes
No
Yes
No
graysccontralateral symptoms has been observed also in the med-
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56 strokes in 1057 patients without, and 39 strokes in 375
patients with a history of contralateral symptoms (OR,
2.06; 95% CI, 1.35-3.16).12
Mild to moderately raised serum creatinine is an inde-
pendent predictor of cardiovascular risk and particularly
ischemic stroke in asymptomatic individuals and patients
with peripheral vascular disease.38,39 In our study, creati-
nine levels higher than 100 mol/L were associated with
hypoechoic plaques (data not shown).
Other established risk factors such as hypertension and
hypercholesterolemia were either weakly associated with
CORI events or not significant probably because they were
present in the majority of the patients.
The inclusion criteria in our study provided a wide
range of stenosis (50% to 99% ECST). This allowed classi-
fication into subgroups of mild, moderate, and severe de-
gree of stenosis and better evaluation of this risk factor in
contrast to other published studies that had excluded upper
or lower extremes of the range of stenosis.1-8 Because
ECST stenosis is linearly related to ipsilateral CORI event
and stroke risk, and NASCET stenosis is not,28 the ECST
measurement has been used in the analysis of our data.
Only one previous prospective study has recruited patients
within the full range of 50% to 99% ECST stenosis as used
in our study7 and graded the stenosis as mild (50%),
moderate (50% to 79%), and severe (80% to 99%). This
study, which involved 678 patients with a mean follow-up
of 3.6 years, showed an increasing ipsilateral CORI event
and stroke rate with increasing grades of stenosis.
The carotid plaque area has already been reported to be
Fig 3. Calibration plot for model (iii), based on all 1121 patients
(– – – shows the line of perfect agreement between predicted and
observed 5-year stroke risk).a strong predictor of MI and stroke23 in patients with milddegrees of stenosis. Our results show that the plaque area
can be used to stratify cerebrovascular risk in patients with
plaques producing moderate and severe stenosis (Fig 1,C).
The measurement of GSM after image normalization is
now an established reproducible measurement of overall
plaque echodensity. Our study confirms the findings of
other prospective studies21,22 that a low GSM is a strong
predictor of future strokes.
Plaque heterogeneity has already been shown to be
associated with symptomatic plaques.24 With the exception
of calcified plaques, it is the result of presence of DWAs
without acoustic shadow in hypoechoic areas. These DWAs
are often hyperperfused as shown by ultrasonic contrast
perfusion agents and correspond to neovascularization
and increased numbers of macrophages on histology.40
Whether the presence of these areas are responsible for the
development of intraplaque hemorrhage, non uniform
plaque stresses promoting plaque rupture or erosion of the
fibrous cap merits further investigation.
This study is unique not only because of the relatively
large number of patients studied, but also because, in
contrast to previous studies that had concentrated on one
feature only, it shows how plaque characteristics add signif-
icantly to the risk stratification potential of stenosis and
clinical features. It also provides a method that allows
estimation of risk for any patient.
Ultrasonic imaging is, to a certain extent, operator
dependent. This has been overcome by training ultra-
sonographers in equipment presets and image capture; also,
by performing image normalization with computerized
analysis at the coordinating center (see online supplement).
The importance of training vascular ultrasonographers in
equipment settings and plaque imaging for optimal results
cannot be overemphasized.
A limitation of this study is that the medical management
of patients was according towhat was considered bestmedical
therapy at each center – the biggest factor when it comes to
the relevance to current clinical practice. At each center, the
clinician in charge was free to change therapy according to
changing indications. At the beginning of the study, only 84%
of patients were on antiplatelet therapy and only 25% on lipid
lowering therapy reflecting clinical practice at that time. To-
ward the end of the study, these percentages were 95% and
85%, respectively. However, the intensity of the treatment
varied and, unlike current guidelines, very few patients were
treated to target cholesterol level. In addition, this “freedom”
in management resulted in 129 patients (11.5%) having a
carotid endarterectomy in the absence of symptoms soon after
the results of the ACST were published. Despite this,
follow-up to a CORI event, death, or to the end of the study
was achieved in 87% of patients.
The clinical implication of our findings is that clinical and
ultrasonic plaque features can be used to stratify risk and may
lead to refinement of the indications for carotid endarterec-
tomy. The availability of user-friendly software for image
analysis and automatic calculation of risk can make the
method part of routine practice in the vascular laboratory.
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since this was done internally, that is for the same group of
patients on whom the score was developed. The findings
need to be validated in additional prospective studies using
current optimal medical intervention.
We are grateful to Suzan Francis, Elena Ioannidou, and
Anne Taft for their contribution as administrative managers
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Asymptomatic internal carotid artery stenosis and
cerebrovascular risk stratification
Participating centers. Participating centers had an
active noninvasive vascular laboratory with color duplex
facility, a volume of patients of at least 500 per year, and
staff experienced in the investigation of patients with ex-
tracranial cerebrovascular disease: a neurologist, a vascular
physician or surgeon, and a radiologist. In addition, they
were able to identify on average 15 individuals or patients
with asymptomatic atherosclerotic carotid bifurcation dis-
ease that could be recruited to the study by screening new
attendees (within 3 months) to their practice using ultra-
sound scan.
Quality control. The ultrasound methodology in the
Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS)
study included a set of procedures designed to control
quality and monitor key components of measurements.
These include instrumentation settings, method of record-
ing data, standardization of the method of scanning, and
personnel training at the coordinating center. Throughout
the study, performance was compared to the set standards.
Results of the quality control, already published,1 indicate
that the goal of prospectively controlling quality in the
ACSRS study had been achieved.
Grading of internal carotid stenosis. Velocities were
obtained at the point of maximum stenosis in the internal
carotid artery and the center of the common carotid artery
lumen with the beam of ultrasound at 60° to the direction
of flow. Because absolute velocity measurements could
underestimate stenosis (eg, in the presence of cardiac ar-
rhythmia) or overestimate stenosis (eg, in the presence of
severe contralateral disease), ultrasonographers at each cen-
ter were trained to use a combination of absolute velocity
measurements and velocity ratios (Table I).2-11 In plaques
that were not calcified, anatomical criteria using color flow
or power Doppler imaging of the artery in transverse sec-
tion (percent diameter stenosis from measurements of ves-
sel and residual lumen diameter at the site of maximum
stenosis) were used to supplement velocity criteria.12-15
The entire duplex examination was recorded on S-VHS
videotape and sent to the coordinating center as part of the
quality control. Contralateral internal carotid artery (ICA)
occlusion was noted.
Bilateral vertebral artery flow was reported as cephalad,
reversed, or not visualized.
Recording of plaque images. A high frequency lin-
ear array transducer was used and the following technical
ultrasound settings were observed to ensure optimum
image quality for plaque type classification and texture
analyses.
1. Maximum dynamic range was used which ensured the
greatest possible display of grayscale values.
2. Persistence was set on low and frame rate on high, the
latter ensuring good temporal scale values.3. The time gain compensation curve (TGC) was sloping
through the tissues but was positioned vertically
through the lumen of the vessel because there was little
attenuation of the ultrasound beam as it passed through
blood. This ensured that the brightness of the adventitia
of the anterior and posterior walls was similar.
4. The overall gain was adjusted to give optimum image
quality. This was achieved by adjustment of the gain
control to minimize but not abolish noise.
5. The most linear post-processing available curve was
used.
6. The ultrasound beam was at 90° to the arterial wall.
7. The minimum depth was used so that the plaque occu-
pied a large part of the image.
The above settings were essential prerequisites for
plaque texture analysis, which was performed at the coor-
dinating center. Ultrasonographers from participating cen-
ters attended for 2-day training at the coordinating center.
They were trained, not only on equipment settings and
method of image recording, but also on the method of
image normalization. Although they were not expected to
perform image normalization, it was felt that knowledge of
how it was done would ensure that all prerequisites for
image analysis described above would be included. A spe-
cially prepared video recording with instructions on how to
perform the examination was provided. Video recordings
of the examination and frozen images of plaques were sent
to the coordinating center for image analysis. Continuous
feedback ensured quality.1
Determination of baseline plaque characteristics
Image normalization and segmentation. Images
that were recorded on videotapes were digitized off-line on
a PC using a video grabber card (Videologic, TV Snap
version 1.0.3 c 1994) at a resolution of 640 480 pixels at
the coordinating center by two members of the team who
were experienced in carotid scanning. Image normaliza-
tion, standardization, and analysis were performed by the
same members of the team.
The “Plaque Texture Analysis software” version 3.2
(Iconsoft International Ltd, Greenford, London, UK)16
which is a dedicated research software package was used.
Normalization was performed with the “Image Normaliza-
tion” module using linear scaling with blood (grayscale
value assigned: 0) and adventitia (grayscale value assigned:
190) as reference points as previously described.16,17 First,
a sample of “blood” was selected from the vessel lumen
avoiding areas of “noise.” Next, using the zoom facility, the
brightest part of adventitia adjacent to the plaque was
magnified at least four times and the middle two-fourths
were selected (Fig 1). The normalized image appeared
automatically in the window next to the original image and
was saved as a separate file with “n” added as the last letter
to the original name. The normalized image was then
standardized to a pixel density of 20 pixels per millimeter
using the bicubic method available in the “Pixel Density
Normalization” module and saved in the database as a
ASCE
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quently used to register the scale distance (usually 10 mm)
as shown on the side of the image. The “Image Crop”
module was then used. This had two windows, one for the
normalized black and white image and the other for the
Fig 1. For image normalization a sample of “blood” free of noise
and a sample from the inner two-fourths of the brightest part of the
adventitia adjacent to the plaque are obtained.
Table I. Duplex velocity criteria used in the ACSRS study
Angiographic
diameter stenosis
N % E % PSVIC
4,5 EDVIC
4-6 P
12 50 120 40
30 60
47 70 120-150 40-80
60 77 150-250 80-130
65 80
70 83 130
82 90 250
90 95
99 99
ACSRS,Asymptomatic Carotid Stenosis and Risk of Stroke;CC, common ca
carotid; N, North American Symptomatic Carotid Endarterectomy Trial (Ncolor flow image for guidance. Visualization of the colorflow or power Doppler images as recorded by the ultra-
sonographers enabled the operator to identify the dark
areas of plaque adjacent to the lumen (absence of color) and
the areas of ulceration (presence of color). The “Log Im-
age” facility that allowed a temporary logarithmic transfor-
mation of the image producing a better definition of the
plaque outline was subsequently used. The plaque outline
was then traced with the mouse and the plaque area within
this outline was saved as a separate plaque image file with
the same name and extension “.plq”. Care was taken not to
include adventitia. Both components of a plaque (anterior
and posterior wall) could be selected. For plaques with a
calcified cap, both the calcified area and the area of the
plaque adjacent to the calcification that was outside the
acoustic shadow were included.
Using the “Feature Extraction” module produced a
variety of texture features that were automatically calcu-
lated including plaque type, grayscale median (GSM), and
plaque area. These features were automatically saved in a
text database that could be opened by “Microsoft Office
Excel” (Microsoft Inc, Redmond, Wash) or SPSS for sub-
sequent statistical analysis. Plaque images were automati-
cally contoured and color-coded. Pixels with gray values 0
to 24 were colored black, 25 to 49 in blue, 50 to 74 in
green, 75 to 99 in yellow, 100 to 124 in orange, and pixels
greater than 124 in red (Fig 2).
The definitions and reproducibility of texture features
used in this study are given below.
GSM. This was the median of the gray values of all the
pixels in the plaque image.16-19 In a reproducibility study of
35 plaques measured by two observers, the interobserver
mean difference of GSM was 3.6, the within-subject SD
was 13.6, and the intra-class correlation coefficient was
0.93.16
Plaque type. Plaques were classified automatically by
the software into the following types according to a modi-
fied Geroulakos classification20,21 as defined below.
Type 1. Uniformly echolucent (black): 15% of the
pixels in the plaque area were occupied by pixels with
om Nicolaides et al,3 1996)
uplex velocity criteria
/PSVCC
7-9 PSVIC/EDVCC
10,11 EDVIC/EDVCC
1.5 7 2.6
7-10
.5-2
-3.2
.2-4 10-20 2.6-5.5
4 20-30
30 5.5
kle flow
E,European Carotid Surgery Trial; EDV, end-diastolic velocity; IC, internal
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rotid;grayscale values 25.
toure
, GS
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 6 Nicolaides et al 1496.e3Type 2. Mainly echolucent: pixels with grayscale
values 25 occupy 15% to 50% of the plaque area.
Type 3. Mainly echogenic: pixels with grayscale val-
ues 25 occupy 50% to 85% of the plaque area.
Type 4 or 5. Uniformly echogenic: pixels with gray-
scale values 25 occupy 85% of the plaque area.
Examples of type 1 to 4 plaques are shown in Fig 2,A-D.
A reproducibility study involving 1062 plaques classi-
fied visually by one observer after image normalization and
automatically by the software had a kappa statistic of 0.61
Fig 2. Examples of normalized grayscale and color con
absent; (B) Type 2, GSM 18, DWA present; (C) Type 3(P .001). Because of the low event rate in plaque types 4and 5 as previously demonstrated,21 and because the soft-
ware cannot distinguish between them, these plaque types
have been grouped together.
Plaque area. This was calculated by the software using
the distance scale on the side of the image frame for
calibration and the plaque area outlined by the operator. It
was expressed in mm2.16,22 In a reproducibility study in-
volving 50 plaques, the interobserver intraclass correlation
coefficient was 0.73.
Discrete white areas. The presence of discrete white
d images of “cut” plaques. (A) Type 1, GSM 2, DWA
M 28, DWA present; (D) Type 4, GSM 98, DWA n/a.areas (DWAs) defined as areas with pixels having grayscale
JOURNAL OF VASCULAR SURGERY
December 20101496.e4 Nicolaides et alvalues 124 (colored red by the software for easy visual
identification) not producing acoustic shadowing in plaque
types 1 to 3 was noted (Fig. 2, B and C). A reproducibility
study involving 80 plaques classified visually after image
normalization by two observers for presence or absence of
DWAs had a kappa statistic of 0.83 (P  .01).
Plaque ulceration. This was defined as a defect2 
2 mm on the surface of the plaque shown by color flow or
power Doppler to be communicating with the vessel lu-
men. It was reported by the ultrasonographers from each
partner center.23
Calculation of predicted 5-year stroke-free survi-
val. The hazard ratios for covariates presented in Table IV
(iii) in the printed article can be combined with the baseline
survival function to predict 5-year stroke-free survival prob-
abilities for a patient with a given set of covariates.
For an individual with baseline covariate values (close
to mean covariates) as listed in Table II above, the stroke-
free survival at 5 years S0 (5y) is estimated as 0.972.
Predicted 5-year stroke-free survival for a patient with differ-
ent values of the covariates than those in Table II can be calcu-
lated as follows:
1. Transform continuous covariates using the formulae
given in Table II, third column.
2. Using these (possibly transformed) values, calculate the
differences, x, between the value you are interested in
and the values used in S0 (5y) (Table III, second
column).
3. Multiply each of these differences by the corresponding
log-hazard ratio, , from Table IV (iii) in the printed
Table II. Baseline covariates and transformed values in
an individual
Covariate
Baseline
value
Corresponding
transformations
Stenosis, % 80 None
GSM 30 ln (GSM40)  4.248
Plaque area, mm2 40 mm2 (Plaque area)1/3  3.420
DWAs Absent 0
History of contralateral
TIAs and/or stroke Absent 0
DWAs,Discrete white area;GSM, grayscalemedian;TIAs, transient ischemic
attacks.
Table III. Steps 2 and 3 in the calculation of 5-year
predicted stroke-free survival
Variable Calculation 
  

Stenosis 90-80 10 0.026 0.2600
ln (GSM40) 3.912-4.248 	0.336 	2.672 0.8978
(Plaque area)1/3 4.309-3.4200 0.889 0.629 0.5592
DWAs 1-0 1 0.429 0.4290
History of contralateral
TIAs and/or stroke 0-0 0 0.973 0
DWAs,Discrete white area;GSM, grayscalemedian;TIAs, transient ischemic
attacks.article to obtain x as shown in Table III, column 5.4. Sum the values obtained in step 3 above to denote this
as x.
5. Calculate exp (x).
6. Compute predicted survival probability as a percentage
for a patient using 100  0.972 exp (x).
Following this calculation for a patient with 90% stenosis,
GSM  10, plaque area  80 mm2, DWAs present, and
history of contralateral TIAs, and/or stroke absent (Table
III):
1. ln (GSM40)  3.912; (Plaque area)1/3  4.309.
4. Sum of x  x  0.2600  0.8978  0.5592 
0.4290  0  2.1460.
5. Exp (2.146)  8.551.
6. Predicted 5-year stroke-free survival 100 
0.972exp (2.146)  78.4%.
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